Boras, Britton
Jones, Rhys M. http://orcid.org/0000-0002-5263-9194
Anson, Brandon J. http://orcid.org/0000-0003-2670-974X
Arenson, Dan
Aschenbrenner, Lisa
Bakowski, Malina A. http://orcid.org/0000-0002-3337-6528
Beutler, Nathan http://orcid.org/0000-0003-3240-9524
Binder, Joseph
Chen, Emily
Eng, Heather http://orcid.org/0000-0002-2914-3967
Hammond, Holly
Hammond, Jennifer
Haupt, Robert E.
Hoffman, Robert http://orcid.org/0000-0002-2030-9094
Kadar, Eugene P.
Kania, Rob
Kimoto, Emi http://orcid.org/0000-0003-1284-2769
Kirkpatrick, Melanie G.
Lanyon, Lorraine
Lendy, Emma K.
Lillis, Jonathan R.
Logue, James http://orcid.org/0000-0002-7410-9741
Luthra, Suman A.
Ma, Chunlong http://orcid.org/0000-0002-5766-8189
Mason, Stephen W.
McGrath, Marisa E. http://orcid.org/0000-0002-7451-4958
Noell, Stephen
Obach, R. Scott
O’ Brien, Matthew N.
O’Connor, Rebecca
Ogilvie, Kevin http://orcid.org/0000-0002-1024-2172
Owen, Dafydd
Pettersson, Martin
Reese, Matthew R. http://orcid.org/0000-0002-1066-2652
Rogers, Thomas F. http://orcid.org/0000-0001-9756-327X
Rosales, Romel http://orcid.org/0000-0001-5326-4753
Rossulek, Michelle I.
Sathish, Jean G.
Shirai, Norimitsu
Steppan, Claire
Ticehurst, Martyn
Updyke, Lawrence W.
Weston, Stuart http://orcid.org/0000-0001-9840-2953
Zhu, Yuao
White, Kris M. http://orcid.org/0000-0003-0889-0506
García-Sastre, Adolfo http://orcid.org/0000-0002-6551-1827
Wang, Jun http://orcid.org/0000-0002-4845-4621
Chatterjee, Arnab K.
Mesecar, Andrew D.
Frieman, Matthew B. http://orcid.org/0000-0003-0107-0775
Anderson, Annaliesa S. http://orcid.org/0000-0002-6413-1718
Allerton, Charlotte http://orcid.org/0000-0001-8665-159X
Funding for this research was provided by:
Pfizer
U.S. Department of Defense (W81XWH-20-1-0270)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI142733, U19AI135972)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 22 January 2021
Accepted: 23 September 2021
First Online: 18 October 2021
Competing interests
: A.D.M. and affiliates (B.J.A., E.K.L.) have a sponsored program contract with Pfizer to test compounds for inhibition of coronavirus proteases. J.W. and affiliate (C.M.) have a sponsored research agreement with Pfizer to test compounds for inhibition of coronavirus proteases. The Frieman Laboratory (M.B.F., H.H., R.E.Ha., J.L., M.E.M., S.W.) was funded by Pfizer for the work in this manuscript. The García-Sastre Laboratory (AG-S, KMW, RR) has received research support from Pfizer, Senhwa Biosciences, Accurius, Avimex, 7Hills Pharma, Pharmamar, Blade therapeutics, Dynavax, Kenall Manufacturing, ImmunityBio and Nanocomposix; and AG-S has consulting agreements for the following companies involving cash and/or stock: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Valneva, Accurius, and Esperovax. AG-S is inventor in patent applications on SARS-CoV-2 antivirals owned by Icahn School of Medicine at Mount Sinai. B.B., R.M.J., D.A., L.A., J.B., H.E., J.H., R.Ho., E.P.K., R.K., E.K., L.L., J.R.L., S.A.L., S.W.M., S.N., R.S.O., M.N.O., R.O., K.O., D.O., M.P., M.R.R., M.I.R., J.G.S., N.S., C.S., M.T., L.W.U., Y.Z., A.A., and C.A., at the time of their contributions were employees and may have stock in Pfizer. A.K.C., M.A.B., N.B., E.C., M.G.K., T.F.R. have no competing interest to report.